Renal allograft outcome from cytomegalovirus seronegative donor into cytomegalovirus seronegative recipient: poor prognosis after seroconversion

Transplant Proc. 2000 Mar;32(2):408-10. doi: 10.1016/s0041-1345(00)00834-4.

Authors

T Besse¹, J Malaise, M De Meyer, M Mourad, J P Squifflet

Affiliation

¹ Department of Renal Transplantation Cliniques Universitaires Saint-Luc, Brussels, Belgium.

PMID: 10715458
DOI: 10.1016/s0041-1345(00)00834-4

No abstract available

MeSH terms

Adult
Antiviral Agents / therapeutic use
Cytomegalovirus Infections / epidemiology*
Follow-Up Studies
Ganciclovir / therapeutic use
Graft Rejection / epidemiology*
Graft Survival
Histocompatibility Testing
Humans
Kidney Transplantation / immunology
Kidney Transplantation / mortality
Kidney Transplantation / physiology*
Living Donors
Pancreas Transplantation
Postoperative Complications / epidemiology*
Prognosis
Retrospective Studies
Survival Analysis
Time Factors
Tissue Donors

Substances

Antiviral Agents
Ganciclovir